To the full analysis
Laurus Labs stock: growth
LAURUSLABS.NSLaurus Labs reported $724.13M in revenue for fiscal 2026, up 22.7% on the prior year, up 7.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
18.9%
per year from 2013 to 2026, per share 16.3%
Earnings (Annual rate)
19.4%
per year from 2013 to 2026, per share 16.9%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2013 | |
|---|---|---|---|
| Revenue | 7.2% | 14.4% | 18.9% |
| Revenue per share | 7.1% | 13.3% | 16.3% |
| Earnings | −2.0% | 20.9% | 19.4% |
| Earnings per share | −2.1% | 19.7% | 16.9% |
| Free cash flow | 54.5% | no data | no data |
| Free cash flow per share | 54.4% | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2013 | $76.37M | $9.38M | −$3.24M |
| 2014 | $141M | $7.27M | −$19.97M |
| 2015 | $141M | $7.27M | −$47.6M |
| 2016 | $188.94M | $14.21M | −$15.27M |
| 2017 | $202.44M | $20.22M | $5.79M |
| 2018 | $218.55M | $17.82M | −$5.17M |
| 2019 | $243.6M | $9.97M | $4.61M |
| 2020 | $300.98M | $27.13M | $13.31M |
| 2021 | $511.62M | $104.54M | $4.7M |
| 2022 | $524.59M | $87.96M | $3.64M |
| 2023 | $642.04M | $83.98M | $397.52K |
| 2024 | $535.78M | $17.06M | −$1.34M |
| 2025 | $590.32M | $38.09M | −$4.18M |
| 2026 | $724.13M | $94.47M | $41.39M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong since 12 Nov 2026, previously Neutral
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.